TI
SBBP

Trexquant Investment’s Strongbridge Biopharma plc. SBBP Stock Holding History

Trexquant Investment’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,086
Closed -$138K – 1493
2017
Q4 		$138K Buy
+19,086
New +$119K 0.02% 985

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Trexquant Investment's SBBP Position: Q1 2018 in Review

Trexquant Investment sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2018, closing a stake of 19,086 shares — an estimated $138K sold.

Trexquant Investment first reported a position in SBBP in Q4 2017 and held it in 1 quarter. The position peaked at $138K in Q4 2017. 65 funds tracked by Wall St. Rank hold SBBP as of Q1 2018.

  • Trexquant Investment reported no remaining Strongbridge Biopharma plc. position as of Q1 2018 after selling out during the quarter.
  • Trexquant Investment sold 19,086 Strongbridge Biopharma plc. shares in Q1 2018, an estimated $138K.
  • Trexquant Investment first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 1 quarter.
  • Trexquant Investment's Strongbridge Biopharma plc. position peaked at $138K in Q4 2017.
  • 65 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.